John Dickerson, MD
Neurological Surgery · Wichita, KSNPI 1225059025
Payments from drug & device makers
What this record shows
The money is spread across several categories — other (52.5%), ownership interests and food and beverage — rather than concentrated in one kind of arrangement. Midwest Surgical Alliance, LLC accounts for 100.0% of it on its own, with 5 other manufacturers making up the rest. 2025 is the largest year on record at $355,285, 2.2 times the $162,142 reported in 2019. Among neurological surgery clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 12 payments — averaging $158,823 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Midwest Surgical Alliance, LLC$1.9M
- Surgalign Spine Technologies, Inc.$39
- Aesculap, Inc.$31
- Kuros Biosciences USA, Inc$26
- Cerapedics Inc.$19
- Boston Scientific$19
Across 7 payments — averaging $37,189 each. An ownership or investment interest held by the physician or an immediate family member.
- Midwest Surgical Alliance, LLC$260K
What the payments were for
- Food & beverage$1320%
- Ownership interest$906,05648%
- Other$999,68552%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Midwest Surgical Alliance, LLC | 7 | $1,905,741 |
| Surgalign Spine Technologies, Inc. | 1 | $39 |
| Aesculap, Inc. | 1 | $31 |
| Kuros Biosciences USA, Inc | 1 | $26 |
| Cerapedics Inc. | 1 | $19 |
| Boston Scientific | 1 | $19 |
How this compares
$1,905,873 in reported general payments places this provider in the 95th percentile of 63 neurological surgery providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 245 | $4,078 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 244 | $2,651 |
| Methocarbamol | 85 | $1,360 |
| Methylprednisolone | 58 | $396 |
| Oxycodone Hcl | 36 | $382 |
| Tizanidine Hcl | 41 | $298 |
| Gabapentin | 48 | $266 |
| Minocycline Hcl | 15 | $154 |
| Cephalexin | 14 | $83 |
| Cyclobenzaprine Hcl | 11 | $79 |
| Tramadol Hcl | 21 | $76 |
| Meloxicam | 18 | $54 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Wichita
- Raymond GrundmeyerWichita$1.9M
- Matthew HenryWichita$1.9M
- Nazih MoufarrijWichita$5K
- Zsolt ZadorWichita$3K
- Thomas FrimpongWichita$2K
- Ashley BarksWichita$952
- James WeimarWichita$106
- Christian LothesWichita$92
- Frank HolladayKansas City$349K
- Koji EbersoleKansas City$123K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.